Improved workflow aids cystic fibrosis gene therapy research

Researchers in the UK are at the forefront of developing a gene therapy for cystic fibrosis, an inherited disease that affects 50,000 individuals around the world. Although various organ systems are involved, it is lung disease that is most significant in terms of morbidity and mortality. Here, research scientist Stephanie Sumner-Jones explains how the ABgene SuperPlate is making a difference to her work.